KBiobox

08/09/2019

Michael Powell July 2019 CSO DiaCarta Inc
"KBioBox is an excellent resource for genomic analysis and gene editing CRISPR gRNA design and off-target analysis they helped us immensely in our CRISPR gene-editing projects".(Science Exchange)

06/20/2019

Showing our GENE EDIT DESIGN, OFF TARGET, AND EXTENDED GUIDE-SEQ Bio-informatics at World Pharma Week, Boston. A great 4 days.😀👍

06/14/2019

KBioBox LLc is attending WORLD PHARMA WEEK 2019 Boston June 17 - 20th.
Hope to see you there! Arrange meeting Brella 1-ON-1. Gene Editing, Off Target, Extended Guide-See.

06/04/2019

KBIOBOX llc (Bio-Informatic Services) JOINS SCIENCE EXCHANGE.

SCIENCE EXCHANGE is the world’s leading online R+D Market Place enabling providers to access and engage customers and streamline the sales and delivery of R+D services. Conversely Science Exchange enables buyers to engage with service providers with a simple one stop solution.
KBIOBOX is powered by proprietary patented genomic search technology, currently offering applications built upon the technology: Gene Editing Design, Off-Target Analysis, and extended GUIDEseq Analysis.
KBIOBOX was awarded “Best Bio-Informatics Engine Technology 2018- USA” by Global Health and Pharma.

KBIOBOX currently lists 7 Genomic Bio-informatic services. https://www.scienceexchange.com/labs/kbiobox-llc

1) - Off Target Genome Editing Analysis
2) - Crispr Design to Validation
3) - Talon Design and Validation
4) - Extended Guide Seq Analysis
5) - Crispr Bio-Informatics
6) - Bio-Informatics
7) - Software Development

Get Competitive Quotes From KBioBox LLc On Science Exchange, The Worlds Leading Online Science Marketplace. Fast & Secure.

01/28/2019

KBIOBOX awarded “BEST BIO-INFORMATICS ENGINE TECHNOLOGY 2018 – USA” By Global Health and Pharma (gph). Jan 25 2019.

KBioBox is delighted to announce that Global Health and Pharma (gph) awarded KBioBox
“Best Bio-Informatics Engine Technology 2018 – USA”.
Last month KBioBox announced the signing of a second license agreement with Poseida Therapeutics Inc to provide custom Bio-Informatic analysis for CRISPr based systems.
Recently KBioBox added Gene Edit Secondary Analysis ( Cleavage, repair, and translocation) to its established Gene Edit and Design Platform enabling scientist to postcede every gene edit experience with KBioBox’s secondary analysis to gain vital information to exact results of the edit, identify actual cleavage sites, correct and incorrect pairs, observed and potential translocations and changes to peptide/protein sequences.
KBioBox’s better Guide-Seq Analysis is used to extend standard GUIDE-Seq analysis or any analogous gene edit pipeline and provides easier to read reports, additional analyses on nuclease fidelity and other off target analysis.
For Enquiries please contact us at [email protected] and see www.kbiobox.com

12/11/2018

KBIOBOX HAS SIGNED A SECOND LICENSE AGREEMENT WITH POSEIDA THERAPEUTICS INC, to provide custom bioinformatic analysis for CRISPR based systems. Recently KBioBox launched a portal incorporating an easy “3 click” gene editing design and off target analysis system https://www.kbiobox.com/ Just enter a) Cell line b) Gene edit type c) Design. Video. https://lnkd.in/gSRC4xA. Users can enter one off target analysis project for FREE and receive, actionable results in minutes. https://lnkd.in/gDeMhB7 .For GENE EDIT DESIGN ANALYSIS Enter a) Location b) Search type c) Edit Type. Video https://lnkd.in/gpzGEaz in under a minute KBioBox determines the “top ten” designs and produces a report with visualizations and whole genome off target analysis for each design: KBioBox llc. is a BioInformatics company specializing in the analysis of gene edit off targets, gene edit design, extended GuideSeq, pathogen identification and other custom analysis.KBioBox technology is customizable to any bioinformatic application improving the quality of results and time line.

06/09/2018

Houston Methodist Hospital and Research Institute acknowledges KBioBox's powerful Bioinformatics Engine for Genetic and Microbiome Data Analysis in the latest Molecular Oncology white paper https://febs.onlinelibrary.wiley.com/doi/epdf/10.1002/1878-0261.12320 …

11/01/2017

KBioBox The Genetic BioInformatic Data and Analysis Experts Publish Standard Service Price List., http://www.prweb.com/releases/2017/11/prweb14869365.htm -

(PRWEB) November 01, 2017 -- KBioBox is pleased to announce that they have published their standard services and prices directly to their website. Find prices quickly for Gene Edit Design, Gene Edit Off Target Analysis and Extended Guide-Seq Analysis (Individually or as packages).

11/01/2017

http://www.prweb.com/releases/2017/11/prweb14869058.htm

(PRWEB) November 01, 2017 -- KBioBox is Pleased to Announce that Agenovir Corp Selected KBioBox's Proprietary Gene Edit Design Tool and Secondary Analysis to Assist in Their Quest to Develop Novel Antiviral Therapeutics.

10/26/2017

Kbiobox is pleased to announce that our latest Gene Edit Design Tool can Design against multiple reference Genomes.

Worcester. Mass (PRWEB) October 26, 2017 -- KBioBox's New Genetic Analysis Includes a Gene Edit Design Tool That Can Now Design Against Multiple Reference Genomes Including Viral Reservoirs or Pathogenic Bacteria While Considering Off Target Effects In a Eukaryotic Host model.

08/22/2017

KBioBox is pleased to announce new Algorithms which improve the GUIDE-Seq analysis Pipeline for CRISPR experiments. http://www.prweb.com/releases/2017/05/prweb14375692.htm

Worcester. MA (PRWEB) August 22, 2017 -- KBioBox is pleased to announce the creation of new algorithms built upon patented KBioBox technology to provide Scientists with advanced custom gene editing analysis, extending the capabilities of the open-source GUIDE-seq computational pipeline.